Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chubb
McKesson
Medtronic
Boehringer Ingelheim
Farmers Insurance

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nimotuzumab

« Back to Dashboard

US Patents for Nimotuzumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nimotuzumab ➤ Sign Up Binding molecules specific for HER3 and uses thereof MEDIMMUNE, LLC (Gaithersburg, MD) ➤ Sign Up
Nimotuzumab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Nimotuzumab ➤ Sign Up Anti-EGFR activatable antibodies CytomX Therapeutics, Inc. (South San Francisco, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cipla
Fish and Richardson
McKinsey
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.